400
Participants
Start Date
October 22, 2024
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2027
EYP-1901
Intravitreal Injection
Aflibercept (2.0 mg)
Intravitreal Injection
Retina Consultants PLLC, Slingerlands
Retina Vitreous Surgeons of CNY, PC, Liverpool
Retina Associates of Western NY, PC, Rochester
Erie Retina Research, Erie
Eye Care Specialists - Kingston Location, Kingston
Retina Groups of Washington, Chevy Chase
Retina Specialists, Towson
The Retina Care Center, Baltimore
Cumberland Valley Retina Consultants, Hagerstown
The Retina Group of Washington, Fairfax
Retina Associates, P.C., Winchester
Piedmont Eye Center, Lynchburg
Piedmont Retina Specialists, P.A. - Winston-Salem Office, Winston-Salem
Cape Fear Retinal Associates, PC, Wilmington
Western Carolina Retinal Associates, PA, Asheville
Palmetto Retina Center, Florence
Retina Consultants, Charleston
Retina Consultants of Carolina P.A, Greenville
Gerogia Retina, Marietta
Retina Specialty Institute, Pensacola
Vitreo Retinal Associates, Gainesville
Florida Retina Institute, Orlando
Advanced Research, LLC, Deerfield Beach
MedEye Associates, South Miami
Retina Specialists of Tampa, Tampa
Retina Vitreous Associates of Florida, Tampa
Eye Associates of Pinellas, Pinellas Park
Florida Retina Consultants, Lakeland
Center for Retina & Macular Disease, Winter Haven
Retina Group of Florida, Sarasota
Charles Retina Institute, Germantown
Deep Blue Retina Clinical Research PLLC, Southaven
Midwest Retina, Inc., Dublin
Midwest Eye Institute, Carmel
Retina Associates of Michigan, Grand Blanc
Foundation for Vision Research, Grand Rapids
University of Wisconsin School of Medicine and Public Health (UWSMPH), Madison
Retina Associates, Elmhurst
University Retina and Macula Associates, Lemont
The Retina Institute, St Louis
Retina Associates LLC, Lenexa
Retina Partners of Northwest Arkansas, Springdale
Tulsa Retina Consultant, Tulsa
Texas Retina Associates, Plano
Texas Retina Associates, Dallas
Tyler Retina Consultants, Tyler
Strategic Clinical Research Group, LLC, Willow Park
Retina Center of Texas, Southlake
Houston Eye Associates, Houston
Baylor College of Medicine Alkek Eye Center, Houston
Retina Consultants of Texas, The Woodlands
Retina and Vitreous of Texas, Bellaire
Retina Consultants of Texas (Retina Consultants of Houston) - Woodlands, Bellaire
San Antonio Eye Center, San Antonio
Retinal Consultants of Texas, San Antonio
Retina Research Institute of Texas Integrated Clinical Research, Abilene
RSC Research, PLLC, Denver
Advanced Vision Institute, Longmont
Eye Center of Northern Colorado, PC, Fort Collins
Salt Lake Retina, West Jordan
Retina Associates of Utah, Salt Lake City
Rocky Mountain Retina Consultants, Salt Lake City
Retinal Research Institute, LLC, Phoenix
Vision Research Center at Eye Associates of New Mexico, Albuquerque
Sierra Eye Associates, Reno
Retina Vitreous Associates Medical Group, Beverly Hills
Macula and Retina Institute, Glendale
Retina Consultants San Diego, Poway
Retina Consultants of Southern California, Redlands
Gavin Herbert Eye Institute, Irvine
California Retina Consultants, Bakersfield
West Coast Retina Medical Group, San Francisco
Bay Area Retina Associates, Walnut Creek
American Institute of Research, Whittier
Retinal Consultants Medical Group, Sacramento
Retina Consultants of Hawaii, ‘Aiea
Verum Research LLC, Eugene
Connecticut Eye Consultants, P.C., Danbury
SightSera Clinical Research LLC, Greenwich
Retina Group of New England, PC, Waterford
Maine Eye Center, Portland
Ophthalmic Consultants of Boston OCB - Boston, Boston
New England Retina Consultants, Springfield
NJ Retina, Teaneck
NJ Retina, Toms River
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
INDUSTRY